Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Carboplatin and Paclitaxel in Advanced Ovarian Cancer
NCT00331422Phase 2Terminated
- Sponsor
- Masonic Cancer Center
- Start
- Oct 2005
- Primary completion
- Mar 2008
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, carboplatin in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC), sponsored by Masonic Cancer Center. Started Oct 2005; status: terminated.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT00331422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00331422.